Simplified test effective in predicting smoking addiction in cancer patients

Data from nearly 6000 smokers with cancer show that it may be easier to predict who will stop smoking than was previously thought.

FDA approves Astellas’ VYLOY for gastric cancer treatment

VYLOY is used in conjunction with chemotherapy for the treatment of advanced gastric and gastroesophageal junction cancer. Credit: Emily frost/Shutterstock.com. Astellas Pharma has gained approval

October 21, 2024

Shrinkage in the brain’s hippocampus area associated with cognitive decline

With the rise of new drugs that can target the amyloid-beta plaques in the brain that are an early sign of Alzheimer’s disease, new ways

November 16, 2023

J&J makes $2B push into ADCs with Ambrx buyout in oncology deal spree: #JPM24

SAN FRANCISCO — Johnson & Johnson is adding to Big Pharma’s love for antibody-drug conjugates with a $2 billion cash deal to swoop up Ambrx

January 9, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.